Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held N/A

Harold Bernstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 07 2026
SELL
Open market or private sale
$1,011,271 $40.2 p/Share
25,156 Reduced 100.0%
0 Common Stock
Jan 07 2026
BUY
Exercise of conversion of derivative security
$262,125 $10.42 p/Share
25,156 Added 50.0%
25,156 Common Stock
Jan 05 2026
SELL
Open market or private sale
$16,480 $40.0 p/Share
412 Reduced 100.0%
0 Common Stock
Jan 05 2026
BUY
Exercise of conversion of derivative security
$4,293 $10.42 p/Share
412 Added 50.0%
412 Common Stock
Jan 02 2026
SELL
Open market or private sale
$179,185 $40.43 p/Share
4,432 Reduced 100.0%
0 Common Stock
Jan 02 2026
BUY
Exercise of conversion of derivative security
$46,181 $10.42 p/Share
4,432 Added 50.0%
4,432 Common Stock
Dec 29 2025
SELL
Open market or private sale
$1,828,800 $40.64 p/Share
45,000 Reduced 100.0%
0 Common Stock
Dec 29 2025
BUY
Exercise of conversion of derivative security
$468,900 $10.42 p/Share
45,000 Added 50.0%
45,000 Common Stock
HB

Harold Bernstein

President, R&D & CMO
South San Francisco, CA

Track Institutional and Insider Activities on MAZE

Follow Maze Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MAZE shares.

Notify only if

Insider Trading

Get notified when an Maze Therapeutics, Inc. insider buys or sells MAZE shares.

Notify only if

News

Receive news related to Maze Therapeutics, Inc.

Track Activities on MAZE